Previous Study: TRIO041
Next Study: TRIO045

Studies & Results

TRIO042

An open-label, phase II, multicohort, basket trial to evaluate the efficacy and safety of regorafenib in combination with durvalumab in patients with Mismatch Repair-Proficient solid cancers

For information on any of TRIO's clinical trials, please contact Valérie Bee, Director Project Management at valerie.bee@trioncology.org